You searched for bevacizumab

ESMO 2021, News

Adding Bevacizumab to Erlotinib Prolongs PFS in Non-Squamous Non-Small Cell Lung Cancer

September 20, 2021

There was no improvement in overall survival with bevacizumab.

News

Diabetic Macular Edema Outcomes Compared for Aflibercept, Bevacizumab

July 18, 2022

Outcomes at 2 years comparable among patients with diabetic macular edema receiving aflibercept monotherapy, bevacizumab first

News

Bevacizumab, Aflibercept Compared for Neovascular AMD

December 6, 2022

At the end of one year, likelihood of being weaned off treatment was higher for eyes treated with aflibercept versus bevacizumab

News

Anti-VEGF Injections May Reduce Glaucoma Burden for Some

February 8, 2021

Study shows reductions in intraocular pressures and antiglaucoma medication use.

ESMO 2021, News

Pembrolizumab Plus Chemo ± Bevacizumab Prolonged Survival in Cervical Cancer

September 20, 2021

Pembrolizumab plus chemotherapy with or without bevacizumab could be a new standard of care for first-line therapy in metastatic cervical cancer.

News

Keytruda Approved as First-Line Treatment for Persistent, Recurrent or Metastatic Cervical Cancer

October 13, 2021

The approval was based on data from the phase 3 KEYNOTE-826 trial.

News

Some Cancer Drugs Without Proven Benefit Still Recommended

September 14, 2021

Six of 18 indications remain on label for cancer drugs that failed to improve primary end point in trials after receiving accelerated approval

News

Continued Monitoring Needed for Anti-VEGF Therapy in Macular Edema

April 27, 2022

Substantial improvement observed through month 12, which persisted through month 60, but lessened with fewer treatments

Drugs in the Pipeline

Tisotumab Vedotin Under Review for Recurrent or Metastatic Cervical Cancer

April 13, 2021

Tisotumab vedotin is an investigational antibody-drug conjugate targeted to tissue factor.

ESMO 2021, News

Immunotherapy Significantly Improved Survival in Recurrent/Metastatic Cervical Cancer

September 20, 2021

The checkpoint inhibitor cemiplimab improved survival in patients with recurrent/metastatic cervical carcinoma compared with single-agent chemotherapy.

Active Filters

Your search for bevacizumab returned 10 results

Sort Results:

Adding Bevacizumab to Erlotinib Prolongs PFS in Non-Squamous Non-Small Cell Lung Cancer

Diabetic Macular Edema Outcomes Compared for Aflibercept, Bevacizumab

Anti-VEGF Injections May Reduce Glaucoma Burden for Some

Pembrolizumab Plus Chemo ± Bevacizumab Prolonged Survival in Cervical Cancer

Keytruda Approved as First-Line Treatment for Persistent, Recurrent or Metastatic Cervical Cancer

Some Cancer Drugs Without Proven Benefit Still Recommended

Continued Monitoring Needed for Anti-VEGF Therapy in Macular Edema

Tisotumab Vedotin Under Review for Recurrent or Metastatic Cervical Cancer

Immunotherapy Significantly Improved Survival in Recurrent/Metastatic Cervical Cancer